Comment | Sun Pharma: Tying up loose ends

Ravi Ananthanarayanan • April 09, 2019 / 12:12 IST

Sun Pharma has fulfilled its commitments by undoing two transactions that had discomfited investors. If there’s one thing it could have done better, it is making fuller disclosures

To read the full story,

Are you a PRO subscriber? Sign In

Ad free Experience

Seamless navigation, faster responses.
Expert Perspective

Explore 230+ exclusive editorials every month
+

Uncover Insights from World-Renowned Experts and Journalists
Actionable Insights

40+ weekly investment ideas + 3 to 4 daily technical calls
Virtual Events

Exclusive Live Webinars for Expert Trading & Investment Strategies!
Newsletters

Stay ahead with daily and weekly insights

Unlock exclusive discounts